Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
4.060
-0.350 (-7.94%)
At close: Oct 31, 2024, 4:00 PM
4.170
+0.110 (2.71%)
After-hours: Oct 31, 2024, 4:16 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $120.22 million as of October 31, 2024.
Market Cap
120.22M
Enterprise Value
118.47M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.06
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $120.22M, a decrease of -42.00%. That is a compound annual growth rate of -52.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 130.60M | -36.99% |
Feb 9, 2024 | 207.27M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cardiol Therapeutics | 146.42M |
Cardiff Oncology | 145.23M |
Verastem | 144.88M |
American Well | 144.51M |
Inovio Pharmaceuticals | 144.36M |
Akoya Biosciences | 141.07M |
INmune Bio | 139.21M |
Adagene | 137.24M |